B7-H6/NCR3LG1, His, Cynomolgus
B7-H6/NCR3LG1, His, Cynomolgus

The purity of B7-H6/NCR3LG1, His, Cynomolgus is greater than 95% as determined by SEC-HPLC.

B7-H6/NCR3LG1, His, Cynomolgus

B7-H6/NCR3LG1, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

B7-H6/NCR3LG1, His, Cynomolgus

Human NKp30, hFc Tag captured on CM5 Chip via Protein A can bind B7-H6/NCR3LG1, His, Cynomolgus, His Tag with an affinity constant of 0.662 μM as determined in SPR assay (Biacore T200).

B7-H6/NCR3LG1, His, Cynomolgus

B7-H6 is a glycosylated member of the B7 family of immune co‑stimulatory proteins, which is a ligand for the NK cell activating receptor NKp30, was targeted to create a CAR that targets multiple tumor types. B7-H6 is expressed on various primary human tumors, including leukemia, lymphoma and gastrointestinal stromal tumors, but it is not constitutively expressed on normal tissues.
Z04742
¥63,425.00

Ask us a question
Product Introduction
Species Cynomolgus
Protein Construction
B7-H6/NCR3LG1 (Asp25-Asp259)
Accession # XP_005578557.1		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1 EU per μg by the LAL method.
Biological Activity Loaded Human NKp30, hFc Tag on Anti-His-Biosensor can bind B7-H6/NCR3LG1, His, Cynomolgus in BLI assay (Gator® Prime). Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 27.6 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 40-52 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • B7-H6/NCR3LG1, His, Cynomolgus
    • B7-H6/NCR3LG1, His, Cynomolgus

    The purity of B7-H6/NCR3LG1, His, Cynomolgus is greater than 95% as determined by SEC-HPLC.

  • B7-H6/NCR3LG1, His, Cynomolgus
    • B7-H6/NCR3LG1, His, Cynomolgus

    B7-H6/NCR3LG1, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

  • B7-H6/NCR3LG1, His, Cynomolgus
    • B7-H6/NCR3LG1, His, Cynomolgus

    Human NKp30, hFc Tag captured on CM5 Chip via Protein A can bind B7-H6/NCR3LG1, His, Cynomolgus, His Tag with an affinity constant of 0.662 μM as determined in SPR assay (Biacore T200).


Background
Target Background B7-H6 is a glycosylated member of the B7 family of immune co‑stimulatory proteins, which is a ligand for the NK cell activating receptor NKp30, was targeted to create a CAR that targets multiple tumor types. B7-H6 is expressed on various primary human tumors, including leukemia, lymphoma and gastrointestinal stromal tumors, but it is not constitutively expressed on normal tissues.
Synonyms B7H6; B7-H6; DKFZp686I21167; DKFZp686O24166; NCR3LG1; B7 Homolog 6

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.